Author:
Lang Matti A.,Raffalli-Mathieu Françoise
Reference32 articles.
1. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, CoonMJ, Estabrook RW, Gunsalus IC, Nebert DW. 1996 P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics. 6 (1): 1–42
2. Rendic S, Di Carlo FJ. 1997 Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab Rev. 29 (12): 413–580.
3. Porter TD, Coon MJ. 1991 Cytochrome P-450. Multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms. J Biol Chem. 266 (21): 13469–72
4. Waxman DJ. 1999 P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Arch Biochem Biophys. 369 (1): 11–23
5. Zubiaga AM, Belasco JG, Greenberg ME. 1995 The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol Cell Biol. 15(4): 221930.